Academic literature on the topic 'Rhinosinusitis'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Rhinosinusitis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Rhinosinusitis"

1

Gariuc, Lucia, Alexandru Sandul, and Lupoi Daniel. "Invasive fungal rhinosinusitis." Romanian Journal of Rhinology 9, no. 33 (March 1, 2019): 13–19. http://dx.doi.org/10.2478/rjr-2019-0001.

Full text
Abstract:
Abstract Invasive fungal rhinosinusitides are a group of disorders with three subtypes (acute invasive fungal rhinosinusitis, chronic invasive fungal rhinosinusitis and granulomatous invasive fungal rhinosinusitis), requiring urgent diagnosis and early treatment due to the reserved vital and functional prognosis. This disorder occurs in immunocompromised patients, but it can also occur in immunocompetent people. Aspergillus and Mucormicosis species are the most common microorganisms found in invasive fungal rhinosinusites. The otorhinolaryngologic clinical examination and imaging techniques provide important diagnostic information in patients with risk factors for invasive fungal rhinosinusitis, including intracranial or orbital extension identification. The treatment of invasive fungal rhinosinusites (acute or chronic) consists of reversing immunosuppression, appropriate systemic antifungal therapy and aggressive and prompt surgical debridement of the affected tissues.
APA, Harvard, Vancouver, ISO, and other styles
2

Wahid, Fazal-I., Adil Khan, and Iftikhar Ahmad Khan. "Clinicopathological profile of fungal rhinosinusitis." Bangladesh Journal of Otorhinolaryngology 18, no. 1 (April 20, 2012): 48–54. http://dx.doi.org/10.3329/bjo.v18i1.10414.

Full text
Abstract:
Objective: To determine the clinicopathological features of fungal rhinosinusits at a tertiary care hospital.Material and Methods: This study was conducted at the Department of ENT, Head and Neck surgery, PGMI/ LRH Peshawar. This was a four years prospective study from January 2007 to December 2011. All fifty five patients were evaluated thoroughly in terms of history, examination and investigation. Biopsy of nasal mass was performed and biopsy specimens were studied by same histopathologist. After diagnosing the patient as a case of fungal rhinosinusitis surgical procedure was performed according the extent of disease. The data was analyzed using SPSS version 17.Results: These patients were in age range from 11- 66 years with mean age of 37.74 + S.D 16.46 years. They constitute 34 male and 21 female with male: female ratio was 1.6:1. Majority of patients (41.8%) belonged to middle age group. Most of the patients (60%) had lower socioeconomic status and mainly they were from rural area (74.54%) with only 30.9% literacy level. The commonest symptoms of these patients were nasal stuffiness (85.45%). Noninvasive fungal rhinosinusits was on top (87.27%). Aspergillus sp was the common fungal isolates (12.72%).Conclusion: Fungal rhinosinusitis is commonly affecting middle age group people. Allergic fungal rhinosinusitis is the most common entity of fungal rhinosinusitis and Aspergillus is the commonest pathogen. DOI: http://dx.doi.org/10.3329/bjo.v18i1.10414 Bangladesh J Otorhinolaryngol 2012; 18(1): 48-54
APA, Harvard, Vancouver, ISO, and other styles
3

Gariuc, L. "NON-INVASIVE FUNGAL RHINOSINUSITIS. ALLERGIC FUNGAL RHINOSINUSITIS." Folia Othorhinolaryngologiae et Pathologiae Respiratoriae 25, no. 2 (2019): 59–66. http://dx.doi.org/10.33848/foliorl23103825-2019-25-2-59-66.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ivanov, M. O., N. M. Ivanova, M. V. Maksimenya, T. M. Karavaeva, E. V. Egorova, E. V. Fefelova, and N. N. Tsybikov. "Changed content of heat shock proteins and antibodies to them in blood and nasal mucosa cells in rhinites and rhinosinusites of different etiology." Perm Medical Journal 35, no. 6 (December 30, 2018): 23–28. http://dx.doi.org/10.17816/pmj35623-28.

Full text
Abstract:
Aim. To determine the content of heat shock proteins with molecular weight 70 kDa (HSP 70) and antibo dies to them in blood and nasal secretion in patients with allergic rhinites and infectious rhinosinusites of different etiology. Materials and methods. The paper presents the results of examination of 10 patients with allergic rhinitis and 30 patients, infected with rhinosinusites(the age range 25–35 years). The patients with infectious rhinosinusites were divided into 3 groups according to nosologic form of disease. The control group included 10 practically healthy persons in the ratio, comparable by their gender and age with sick persons. Results.The analysis showed that in the nasal secretion of all patients, HSP 70 level significantly raised compared to the control. Maximum values were registered in patients with bacterial rhinosinusitis and were higher than in patients with viral and fungous ones by 1.9 times (p = 0.015) and 2.9 times (p = 0.001), respectively. In blood serum, HSP 70 concentration compared with the control increased in patients with allergic rhinitis and bacterial rhinosinusitis by 103.67 % (p = 0.015) and 32.11 % (p = 0.049), respectively; these values in the last two groups exceeded the latter in patients with fungous RS by 2.37 times (p = 0.01) and by 1.54 times (p = 0.035). Conclusions. It was detected that in the group of patients with allergic rhinitis and chronic bacterial rhinosinusitis in the nasal secretion and blood serum, HSP 70 values were the highest. In the nasal secretion, HSP 70 level was higher than in blood. The amount of autoantibodies to HSP 70 in blood grew in allergic rhinitis, fungous and viral forms of rhinosinusites that reflects the immunological effect of chaperone proteins.
APA, Harvard, Vancouver, ISO, and other styles
5

Kochetkov, P. A., V. A. Svistushkin, and E. S. Shchennikova. "Intranasal glucocorticosteroids for the complex treatment of patients with chronic diseases of the nose and paranasal sinuses." Meditsinskiy sovet = Medical Council, no. 6 (May 27, 2020): 66–70. http://dx.doi.org/10.21518/2079-701x-2020-6-66-70.

Full text
Abstract:
Intriduction. Chronic rhinitis and rhinosinusitis noticeably deteriorate the patients’ quality of life and lead to the accompanying upper airway pathology development. The main purpose of treatment of this group of patients is to decrease severity of symptoms and the second one to prevent complications. The optimal therapy will help patients to maintain their lifestyle. Intranasal glucocorticosteroids are first-line drugs to treat acute rhinosinusitis or exacerbations of chronic rhinosinusitis in adults (including the elderly) and adolescents aged 12 years and older as an auxiliary therapeutic agent if treated by antibiotics, and to treat acute rhinosinusitis with mild to moderate symptoms without signs of severe bacterial infection. In the number of trials, mometasone furoate effectiveness in regard to decreasing of prominent symptoms with no side effects development has been shown.Objective: this article reviews available data on the effectiveness of intranasal corticosteroids – mometasone furoate – in the treatment of different forms of chronic inflammatory diseases of the nose and paranasal sinuses.Methods: information for this review was identified through a RISC and MEDLINE databases applying key words.Conclusions: based on the available data, treatment of chronic rhinosinusites and rhinitis should be initiated by conservative therapy. Summarizing information from the available literature we can conclude that treatment by mometasone furoate improve quality of life decreasing clinical symptoms of chronic rhinosinusitis and rhinitis.
APA, Harvard, Vancouver, ISO, and other styles
6

Friedrich, Hergen, Simona Negoias, and Marco Domenico Caversaccio. "Konservative und operative Behandlung der chronischen Rhinosinusitis." Therapeutische Umschau 73, no. 4 (April 2016): 189–96. http://dx.doi.org/10.1024/0040-5930/a000777.

Full text
Abstract:
Zusammenfassung: Die chronische Rhinosinusitis ist ein häufiges, komplexes Krankheitsbild, welches mit ausgeprägten Therapiekosten und deutlicher Beeinträchtigung der Lebensqualität assoziiert ist. Das EPOS2012 beinhaltet den aktuellen Standard für das Management von Patienten mit chronischer Rhinosinusitis für beide definierten Krankheitsentitäten: mit und ohne Polypen. Die Diagnose besteht in der Kombination zwischen Anamnese und endoskopischen oder CT-bildmorphologischen Befunden. Die Therapie einer chronischen Rhinosinusitis sollte sich zum einen an den Beschwerden des Patienten orientieren als auch an dem endoskopischen Befund. Im Zentrum der medikamentösen Therapie der chronischen Rhinosinusits mit und ohne Polypen steht die topische Applikation von Steroiden begleitet von Salzwasserspülung. Bei Ausbleiben von Besserung oder schwereren Formen steht eine Anpassung der Cortisontherapie oder die Operation im Vordergrund. Die funktionelle endoskopische Sinusoperation ist der aktuelle Goldstandard der Nasennebenhöhlenchirurgie. Ziel dieser ist die möglichst schonende Eröffnung der Nasennebenhöhlen um hier eine adäquate und zielführende Belüftung zu ermöglichen und eine Applikation von topischen Medikamenten an der erkrankten Schleimhaut sicherzustellen.
APA, Harvard, Vancouver, ISO, and other styles
7

Edwards, Daniel R., and Tobias Moorhouse. "Rhinosinusitis." InnovAiT: Education and inspiration for general practice 10, no. 10 (August 8, 2017): 569–76. http://dx.doi.org/10.1177/1755738017719096.

Full text
Abstract:
Rhinosinusitis affects many people, and thus, it is a common presentation in primary care. Despite this fact, rhinosinusitis is often overlooked in undergraduate and postgraduate training. Management of rhinosinusitis places a significant burden on both primary and secondary care, with significant financial implications. This article aims to outline the classification, epidemiology, pathophysiology, clinical diagnosis and treatment of rhinosinusitis, in particular identifying red flag symptoms and indications for referral to secondary care.
APA, Harvard, Vancouver, ISO, and other styles
8

Duncavage, James A. "Rhinosinusitis." Current Opinion in Otolaryngology & Head and Neck Surgery 9, no. 1 (February 2001): 1–2. http://dx.doi.org/10.1097/00020840-200102000-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

deShazo, Richard D., and Stephen F. Kemp. "Rhinosinusitis." Southern Medical Journal 96, no. 11 (November 2003): 1055–60. http://dx.doi.org/10.1097/01.smj.0000098989.05383.99.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

DeCastro, Alexi, Lisa Mims, and William J. Hueston. "Rhinosinusitis." Primary Care: Clinics in Office Practice 41, no. 1 (March 2014): 47–61. http://dx.doi.org/10.1016/j.pop.2013.10.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Rhinosinusitis"

1

Sharman, Mellora J. "Mycotic rhinosinusitis in dogs." Thesis, Sharman, Mellora J (2011) Mycotic rhinosinusitis in dogs. Masters by Research thesis, Murdoch University, 2011. https://researchrepository.murdoch.edu.au/id/eprint/5816/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Vaidyanathan, Sriram. "Optimising therapeutic strategies for chronic rhinosinusitis." Thesis, University of Dundee, 2014. https://discovery.dundee.ac.uk/en/studentTheses/337b63fd-4590-4ef9-a55f-8bf447986906.

Full text
Abstract:
The aim of this thesis is to evaluate and optimise current pharmacotherapeutic options in rhinosinusitis. There is often a marked variation in treatment response in those afflicted with chronic rhinosinusitis, both within and between patients, attributable in part to different disease phenotypes/endotypes, poor awareness of treatment optimization options, and trivialization of symptoms by patients and physicians. Characteristically, these factors contribute to a typical remitting and relapsing disease course. The objectives of this work are to improve the therapeutic index and reach of commonly used medications by boosting efficacy whilst reducing concomitant side effects. The third chapter explores the use of initial oral steroids in patients with chronic rhinosinusitis and nasal polyposis, focusing on the role of the ostiomeatal complex in the perpetuation of disease symptoms. Often a short course of oral steroids is used in patients with moderate to severe disease to achieve initial control before maintenance with intranasal steroids. This is termed as a ‘medical polypectomy’ and anecdotally is commonly used in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP). However, the evidence for its efficacy is tenuous and there are no data to evaluate if it indeed re-establishes ostiomeatal sinus complex drainage which is a condicio sine qua non of ensuring long-term symptom resolution. Further, it is known that monotherapy with nasal steroids may result in loss of symptom control. We have therefore in a double-blind placebo controlled trial (Chapter 4) evaluated the effect of this initial induction with oral steroids on subsequent sequential intranasal therapy. Perhaps, however, more crucially we have for the first time comprehensively addressed the safety of both oral and topical steroids in patients with CRSwNP who have other concomitant steroid-dependent illnesses like asthma and COPD. A particularly refractory subset of those with CRSwNP also have aspirin intolerance and asthma. While recent guidelines have recommended more aspirin challenge testing in these patients, it is unclear what the significance of a positive test is in the absence of overt clinical symptoms or in patients with only moderate disease. This is addressed in Chapter 5, as this significant phenotype of aspirin intolerant rhinosinusitis need close monitoring, dose optimization, polytherapy, and in selected cases may be suitable for aspirin desensitization. Penultimately, we evaluate in a double-blind placebo controlled trial (Chapter 6) the tachyphylaxis and rebound congestion that blights the medium to long-term use of sympathomimetic nasal decongestant sprays like oxymetazoline and if this can be reversed by the concomitant use of nasal steroids. We also characterized nasal blood flow as an outcome to evaluate in these patients and its relation to other rhinological outcome measures (Chapter 7).
APA, Harvard, Vancouver, ISO, and other styles
3

Erskine, Sally. "The epidemiology and experience of chronic rhinosinusitis." Thesis, University of East Anglia, 2017. https://ueaeprints.uea.ac.uk/66950/.

Full text
Abstract:
Chronic rhinosinusitis (CRS) is a common and debilitating disorder. There is a deficit of knowledge about the epidemiology of CRS or the experience of sufferers. The aims of the study were to identify differences in socio-economic variables and quality of life between patients with chronic rhinosinusitis and healthy controls, to identify any significant associations between CRS and other medical co-morbidities, psychiatric disease or environmental exposures and to explore the experience of CRS from the perspective of CRS sufferers. This study consisted of a self-reported questionnaire distributed from 30 ENT clinics across the UK, and qualitative interviews with 21 patients with CRS. Additional studies were undertaken to support this work including further qualitative interviews with patients who have disturbed olfaction, and studies to assess new or unproven treatment regimens including a feasibility study for Clarithromycin for CRS and a trial of sodium citrate for hyposmia. No clear differences in socioeconomic variables were identified between cases and controls. CRS was found to be strongly associated with asthma and inhaled allergies as well as significantly impairing quality of life. Quality of life issues were very important to sufferers, and had been poorly addressed, particularly with regards to sense of smell. Further research is needed to better understand and manage CRS although better adherence to current guidelines would improve care in the interim.
APA, Harvard, Vancouver, ISO, and other styles
4

Kysylytsia, S. O. "Conservative methods of treatment of acute rhinosinusitis." Thesis, БДМУ, 2022. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/19365.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Хижня, Ярослава Володимирівна, Ярослава Владимировна Хижня, Yaroslava Volodymyrivna Khyzhnia, В. С. Бабич, and В. І. Ситнік. "Антибіотикотерапія гострого риносинусита." Thesis, Видавництво СумДУ, 2003. http://essuir.sumdu.edu.ua/handle/123456789/9373.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kristo, A. (Aila). "Acute rhinosinusitis during upper respiratory infection in children." Doctoral thesis, University of Oulu, 2005. http://urn.fi/urn:isbn:9514278720.

Full text
Abstract:
Abstract Acute rhinosinusitis is estimated to be one of the most common diseases in childhood. Still, the diagnostics and clinical relevance of this disease are controversial. Bacterial rhinosinusitis cannot be differentiated from mere rhinitis on clinical grounds alone. Abnormal radiologic findings have been found to be common in child and adult volunteers without sinus symptoms and in adults during viral upper respiratory infection. In children, the results of the few placebo-controlled studies on the benefit of antimicrobial treatment of clinically diagnosed acute rhinosinusitis are controversial. Bacteriologic cultures obtained from the middle meatus by rigid nasal endoscopy have been introduced as a way to determine the bacteriology of the maxillary sinus in adults, but they have not been studied in children with acute symptoms. In this thesis, incidental paranasal abnormalitites were found to be common in healthy school children examined by magnetic resonance imaging (MRI). Some of these abnormalities resolved during a follow-up period of 6 months, but new abnormalities appeared in some children. MRI abnormalities of the paranasal sinuses were found to be much more common in children with acute upper respiratory infections, and most of these abnormalities resolve spontaneously. Children with acute rhinosinusitis confirmed clinically and by imaging did not benefit from cefuroxime treatment as compared to placebo. Pathogenic bacteria (Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis) in the nasal middle meatus during acute upper respiratory infection predicted longer duration of the symptoms and signs of common cold. Based on these findings, imaging methods should not be used in the diagnostics of acute rhinosinusitis in children. Similarily, incidental imaging findings of abnormalities in the paranasal sinuses or in children with symptoms of acute rhinosinusitis are not an indication for antimicrobial treatment. Because middle meatal pathogenic bacteria were found to predict prolonged symptoms of upper respiratory infection, a randomized controlled trial is needed to evaluate the clinical value of middle meatal culture in identifying the children who would benefit from antimicrobial treatment during acute respiratory infection.
APA, Harvard, Vancouver, ISO, and other styles
7

Vento, Seija. "Nasal polypoid rhinosinusitis : clinical course and etiological investigations." Helsinki : University of Helsinki, 2001. http://ethesis.helsinki.fi/julkaisut/laa/kliin/vk/vento/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hisir, Selma [Verfasser]. "Nosologie, Komorbiditäten und Kausalitäten der chronischen Rhinosinusitis / Selma Hisir." Ulm : Universität Ulm, 2018. http://d-nb.info/1161008586/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Autio, T. (Timo). "Development and diagnostics of bacterial acute rhinosinusitis in young adults." Doctoral thesis, Oulun yliopisto, 2017. http://urn.fi/urn:isbn:9789526214726.

Full text
Abstract:
Abstract Acute rhinosinusitis (ARS) is a common condition often treated with antibiotics, even though the cause is usually viral. Despite the commonness of ARS, there is limited evidence on the development and diagnosis of bacterial cases. So far, we lack prospective studies where the bacterial cause would have been confirmed with a bacterial culture of the paranasal sinus aspirate. The purpose of the study was to investigate the course of ARS with a prospective inception cohort study among young adults with ARS, using sequential and standardized methods. To differentiate viral and bacterial ARS, maxillary sinus aspiration and a bacterial culture were used as a reference standard for bacterial ARS. Fifty conscripts with ARS were recruited between February and April 2012. Eight patients (16%) had a positive culture from the maxillary sinus aspirate at 9–10 days and thus, had bacterial ARS. Viral and bacterial coinfection resulted in extensive paranasal mucosal abnormalities and increased symptoms during the episode. The paranasal mucosal abnormalities developed rapidly and remained relatively constant during the episode in both bacterial and non-bacterial ARS. A change in inflammatory biomarker levels indicated both local and systemic inflammatory responses, which were strongest at the onset of symptoms. Symptoms or their changes were of little use in diagnosing bacterial ARS, but secretion seen in the nasal cavity, posterior pharynx or middle meatus predicted bacterial ARS quite well. These results suggest that bacterial infection may modify symptoms and paranasal abnormalities already at the beginning of an ARS episode, although the spread of paranasal abnormalities may not be an etiological factor in the development of bacterial ARS. ARS involves local and systemic inflammatory responses, which are strongest at the beginning of the episode. Examination of the nose and throat is recommended for diagnosing bacterial ARS
Tiivistelmä Nenän äkillinen sivuontelotulehdus on tavallinen tauti, jonka hoitoon käytetään paljon antibiootteja, vaikka sen aiheuttaja on useimmiten virus. Bakteerin aiheuttaman tautimuodon kehittymisestä ja diagnostiikasta ei ole julkaistu tutkimuksia, joissa potilaita olisi seurattu taudin alusta lähtien ja bakteerin olemassaolo olisi varmistettu nenän sivuontelosta otetulla bakteerinäytteellä. Tämän väitöskirjatyön tarkoituksena oli selvittää nenän äkillisen sivuontelotulehduksen kulkua käyttämällä toistuvia, standardisoituja menetelmiä. Bakteerin aiheuttama tauti todettiin poskiontelopistolla ja bakteeriviljelyllä. Tutkimukseen osallistui viisikymmentä (50) äkilliseen ylähengitystieinfektioon sairastunutta varusmiestä keväällä 2012. Kahdeksalla (16 %) potilaalla todettiin bakteerin aiheuttama tauti poskiontelopiston avulla 9–10 päivää oireiden alkamisen jälkeen. Viruksen ja bakteerin sekainfektio aiheutti laajemmat sivuonteloiden tulehduslöydökset ja voimakkaammat oireet kuin pelkän viruksen aiheuttama tauti. Sivuonteloiden tulehduslöydökset kehittyivät nopeasti ja pysyivät sekä bakteerin että viruksen aiheuttamassa taudissa varsin muuttumattomina. Tulehdusmerkkiaineiden muutokset osoittivat sekä paikallisen, että yleisen tulehdusreaktion, jotka olivat voimakkaimmillaan taudin alussa. Oireet tai niissä taudin aikana tapahtuneet muutokset eivät osoittautuneet hyviksi merkeiksi bakteerin aiheuttaman taudin toteamiseksi, mutta eritteen näkyminen nenässä, nielussa tai keskikäytävässä ennakoi hyvin bakteerin aiheuttaman sivuontelotulehduksen toteamista. Bakteeri saattaa vaikuttaa oireisiin ja sivuonteloiden tulehduslöydöksiin jo nenän äkillisen sivuontelotulehduksen alussa, mutta tulehduslöydösten laajuus ei välttämättä liity bakteerin aiheuttaman taudin kehittymiseen. Nenän äkilliseen sivuontelotulehdukseen liittyy paikallinen ja yleinen tulehdusreaktio, jotka ovat voimakkaimmillaan taudin alussa. Potilaan nenän ja nielun tutkiminen on tärkeää bakteerin aiheuttaman nenän sivuontelotulehduksen toteamiseksi
APA, Harvard, Vancouver, ISO, and other styles
10

Wallwork, Benjamin, and n/a. "The Anti-Inflammatory Effect of Macrolide Antibiotics in Chronic Rhinosinusitis." Griffith University. School of Biomolecular and Biomedical Science, 2006. http://www4.gu.edu.au:8080/adt-root/public/adt-QGU20070201.160023.

Full text
Abstract:
Chronic rhinosinusitis is a common disorder of chronic inflammation of the upper respiratory tract. It is associated with significant symptoms and impairment of the quality of life of sufferers. Despite recent advances in the medical and surgical management of chronic rhinosinusitis, there remains a population of patients who fail to obtain relief from their symptoms. Chronic inflammation of the mucosa of the nasal cavity and paranasal sinuses is one of the hallmarks of chronic rhinosinusitis. This inflammation is demonstrated by an increased number of chronic inflammatory cells, elevated levels of pro-inflammatory cytokines, increased expression of adhesion molecules and metaplastic changes in the epithelium. The current medical treatments for chronic sinusitis aim to reduce this inflammation and consequently improve symptoms. In recent years, evidence has emerged that macrolide antibiotics have an anti-inflammatory effect that is separate from their anti-bacterial effect. This effect was first described in the treatment of diffuse panbronchiolitis, a disorder of chronic inflammation of the lower respiratory tract. Following the success of macrolides in treating this condition it was trialed in chronic rhinosinusitis. Several open-label trials have subsequently demonstrated a beneficial effect. Laboratory studies have investigated the mechanism of the anti-inflammatory effect of macrolides. These have shown that macrolides effect cytokine production, inflammatory cell apoptosis, expression of adhesion molecules, neutrophil oxidative burst, bacterial virulence and mucociliary function. In this thesis we report a series of experiments designed to further investigate the mechanism of action and clinical effect of macrolides. In vitro studies using whole sections of chronic rhinosinusitis mucosa cultured for 24 hours in macrolide, prednisolone or control showed that macrolide and prednisolone produced significant reductions in the production of interleukin-5, interleukin-8 and granulocyte-macrophage colony stimulating factor. The same cultured specimens also showed a reduction in expression of transforming growth factor-?. No reduction was seen in the expression of the key pro-inflammatory nuclear transcription factor Nuclear factor-?B. In our in vivo experiments, biopsies were taken from chronic rhinosinusitis patients who had received a 3-month course of macrolide. These biopsies showed a reduction in the number of neutrophils present following treatment. There was no reduction in the number of other inflammatory cells or in the expression of TGF-? and NK-?B. We have performed the first ever double-blinded, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Patients receiving macrolide showed significant improvements in saccharine transit time, nasal endoscopic scoring and symptom scores following a 12 week course. Patients with low levels of serum immunoglobulin E showed significantly improved outcomes compared to those with high levels. Interleukin-8 levels in nasal lavage fluid were significantly reduced in the patients with low levels of IgE following macrolide treatment. No improvements in any of the objective or subjective outcome measures were seen in the placebo-treated patients. We have performed a series of experiments investigating the anti-inflammatory effect of macrolide antibiotics from 'the bench to the bedside'. These experiments have provided insight into the mechanism of action of macrolides in the laboratory setting and evidence of a beneficial effect in the treatment of chronic rhinosinusitis patients.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Rhinosinusitis"

1

Thaler, Erica, and David W. Kennedy, eds. Rhinosinusitis. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

1962-, Shapiro Andrew M., ed. Pediatric rhinosinusitis. Alexandria, VA: American Academy of Otolaryngology--Head and Neck Surgery Foundation, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zhang, Luo, and Claus Bachert, eds. Chronic Rhinosinusitis. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-0784-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ramadan, Hassan H., and Fuad M. Baroody, eds. Pediatric Rhinosinusitis. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-22891-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mankekar, Gauri, ed. Invasive Fungal Rhinosinusitis. New Delhi: Springer India, 2014. http://dx.doi.org/10.1007/978-81-322-1530-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. St. Louis: Mosby, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

United States. Agency for Health Care Policy and Research, ed. Diagnosis and treatment of acute bacterial rhinosinusitis. Rockville, Md: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Batra, Pete S., and Joseph K. Han, eds. Practical Medical and Surgical Management of Chronic Rhinosinusitis. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-16724-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Büter, Sandra. Vergleich von Expressionsraten von CRHR1, CRHR2 sowie MC2-Rezeptoren in Nasenschleimhäuten von Patienten mit chronischer Rhinosinusitis mit und ohne Polyposis Nasi sowie mit und ohne allergische Rhinitis. Düsseldorf: Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Reintjes, Staci, and Susie Peterson. Rhinosinusitis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0012.

Full text
Abstract:
Rhinosinusitis is inflammation of the nasal passages and paranasal sinuses, commonly caused by allergies or viral infection. Sinusitis occurs after the development of rhinitis or inflammation of the nasal passages. Rhinitis is most commonly caused by allergens, but it also can be to the result of an infectious or autoimmune process. For rhinitis to progress to rhinosinusitis, there must be obstruction within the ostiomeatal complex, which is the draining center for the maxillary, anterior ethmoid, and frontal sinuses. History and physical exam are more specific than imaging for diagnosis. Complications arising from sinusitis can cause extensive morbidity if not recognized early. The most common complication is periorbital cellulitis arising from ethmoidal sinusitis. Evaluate for severe complications in immunocompromised patients. Adjunctive therapies to relieve nasal obstruction include medications that decrease mucosal edema as well as increase clearance of congestion. Consider avoiding antibiotics if symptoms are of short duration and are consistent with viral sinusitis.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Rhinosinusitis"

1

Abuzaid, Walleed, and Erica R. Thaler. "Etiology and Impact of Rhinosinusitis." In Rhinosinusitis, 1–15. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Loevner, Laurie A. "Radiology: Its Diagnostic Usefulness in Rhinosinusitis." In Rhinosinusitis, 1–19. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Reger, Christine, Christina F. Herrera, Megan Abbott, and Alexander G. Chiu. "Systemic Diseases and Chronic Rhinosinusitis." In Rhinosinusitis, 1–21. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Leung, Roxanne S., Rohit K. Katial, and Todd T. Kingdom. "Reactive Airway Disease and the Management of Samter’s Triad." In Rhinosinusitis, 1–17. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Elden, Lisa, and Lawrence W. C. Tom. "Pediatric Perspectives of Rhinosinusitis." In Rhinosinusitis, 1–18. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Welch, Kevin C., and James N. Palmer. "Spectrum of Fungal Sinusitis." In Rhinosinusitis, 1–16. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bleier, Benjamin S., and Erica R. Thaler. "Complications of Rhinosinusitis." In Rhinosinusitis, 1–11. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Guss, Joel, and Erica R. Thaler. "Adjunctive Surgical Therapies in the Treatment of Rhinosinusitis." In Rhinosinusitis, 1–14. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Eloy, Jean Anderson, and Satish Govindaraj. "Microbiology and Immunology of Rhinosinusitis." In Rhinosinusitis, 1–12. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kölln, Karen A., and Brent A. Senior. "Diagnosis and Management of Acute Rhinosinusitis." In Rhinosinusitis, 1–11. New York, NY: Springer New York, 2008. http://dx.doi.org/10.1007/978-0-387-73062-2_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Rhinosinusitis"

1

Minov, Jordan, Sasho Stoleski, Dragan Mijakoski, Dragana Bislimovska, and Aneta Atanasovska. "Chrinic rhinosinusitis and occupational exposures." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa1898.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kotz, S., S. Teutsch, C. Heiser, U. Straßen, and A. Chaker. "Rezidivierende orbitale Komplikationen bei akuter Rhinosinusitis." In Abstract- und Posterband – 90. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Digitalisierung in der HNO-Heilkunde. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1685782.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kotz, S., S. Teutsch, C. Heiser, U. Straßen, and A. Chaker. "Recurring orbital complications of acute rhinosinusitis." In Abstract- und Posterband – 90. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Digitalisierung in der HNO-Heilkunde. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1685802.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Send, T., KWG Eichhorn, M. Bertlich, P. Korsten, F. Bootz, and M. Jakob. "A rare cause of chronic rhinosinusitis." In Abstract- und Posterband – 89. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Forschung heute – Zukunft morgen. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1639956.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bogaert, S., N. Suchonos, K. van Ackeren, S. Dazert, J. Park, and C. Bachert. "Mapping der Entzündung bei chronisch polypöser Rhinosinusitis." In Abstract- und Posterband – 91. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Welche Qualität macht den Unterschied. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1711952.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ferreira, Diogenes S., Sonia Kaushik, Shyamali Dharmage, Bruce Thompson, Geza Benke, and Michael J. Abramson. "Rhinitis and chronic rhinosinusitis in Melbourne, Australia." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa1141.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Thandi, P., R. K. Mummoorthy, P. Bhadoria, and D. P. Bhadoria. "Rhinosinusitis in Indian Patients of Bronchial Asthma." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6490.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gukasian, E. L. "New possibilities of laboratory diagnostics of rhinosinusitis." In ТЕНДЕНЦИИ РАЗВИТИЯ НАУКИ И ОБРАЗОВАНИЯ. НИЦ «Л-Журнал», 2018. http://dx.doi.org/10.18411/lj-06-2018-47.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gomez, Estephania Candelo, Angela M. Donaldson, and Osarenoma Olomu. "COVID-19-Associated Acute Invasive Fungal Rhinosinusitis." In 31st Annual Meeting North American Skull Base Society. Georg Thieme Verlag KG, 2022. http://dx.doi.org/10.1055/s-0042-1743879.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Back, D., S. Kaulitz, and R. Hagen. "Therapierefraktäre akute Rhinosinusitis einer Jugendlichen – eine seltene Differentialdiagnose." In Abstract- und Posterband – 91. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Welche Qualität macht den Unterschied. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1711914.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Rhinosinusitis"

1

Rabago, David. Nasal Irrigation for Chronic Rhinosinusitis and Fatigue in Patients with Gulf War Syndrome. Fort Belvoir, VA: Defense Technical Information Center, July 2012. http://dx.doi.org/10.21236/ada568066.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rabago, David. Nasal Irrigation for Chronic Rhinosinusitis and Fatigue in Patients with Gulf War Syndrome. Fort Belvoir, VA: Defense Technical Information Center, July 2013. http://dx.doi.org/10.21236/ada592220.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zheng, Peng-ju. Nasal nebulization inhalation of budesonide for chronic rhinosinusitis with nasal polyps: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, April 2020. http://dx.doi.org/10.37766/inplasy2020.4.0108.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography